Division of Biostatistics, Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Division of Biostatistics and Bioinformatics, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA.
J Biopharm Stat. 2020 May 3;30(3):508-520. doi: 10.1080/10543406.2020.1730877.
In this paper, a propensity score-integrated composite likelihood (PSCL) approach is developed for cases in which the control arm of a two-arm randomized controlled trial (RCT) (treated vs control) is augmented with patients from real-world data (RWD) containing both clinical outcomes and covariates at the patient-level. RWD patients who were treated with the same therapy as the control arm of the RCT are considered for the augmentation. The PSCL approach first estimates the propensity score for every patient as the probability of the patient being in the RCT rather than the RWD, and then stratifies all patients into strata based on the estimated propensity scores. Within each propensity score stratum, a composite likelihood function is specified and utilized to down-weight the information contributed by the RWD source. Estimates of the stratum-specific parameters are obtained by maximizing the composite likelihood function. These stratum-specific estimates are then combined to obtain an overall population-level estimate of the parameter of interest. The performance of the proposed approach is evaluated via a simulation study. A hypothetical two-arm RCT and a hypothetical RWD source are used to illustrate the implementation of the proposed approach.
本文提出了一种倾向评分综合复合似然(PSCL)方法,用于在两臂随机对照试验(RCT)的对照臂(治疗组与对照组)中增加来自真实世界数据(RWD)的患者的情况,这些 RWD 数据包含患者水平的临床结局和协变量。考虑将接受与 RCT 对照臂相同治疗的 RWD 患者纳入增强。PSCL 方法首先估计每位患者的倾向评分,即患者处于 RCT 而不是 RWD 的概率,然后根据估计的倾向评分将所有患者分层。在每个倾向评分层内,指定并利用复合似然函数来降低 RWD 源提供的信息的权重。通过最大化复合似然函数来获得各层特定参数的估计值。然后将这些特定于层的估计值组合起来,以获得感兴趣参数的总体人群水平估计值。通过模拟研究评估所提出方法的性能。使用一个假设的两臂 RCT 和一个假设的 RWD 源来说明所提出方法的实施。